What this means
Researchers plan to check immune response to a pneumococcal vaccine over time. The study is still recruiting, so no results are available yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18 and over · People living with HIV, with no number stated
- Where
- 1 site, including Minnesota
The science
- Registered title
- Vaccine Immunity and Inflammation in the Aging Person Living With HIV
- Trial ID
- NCT06514547 ↗
- Phase
- PHASE 4
- Study type
- interventional
- Conditions
- HIV Infections, Age
- What is tested
- Conjugate Pneumococcal Vaccine 20 (PCV20)
- Sponsor
- Hennepin Healthcare Research Institute
- Ages
- 18 Years to no maximum
- Dates
- First posted Jul 23, 2024 · updated Jun 12, 2025
Registry summary
This study will track immune responsiveness to conjugate pneumococcal vaccines over time to help determine how long protection from this vaccine lasts in individuals with chronic medical conditions (in this study - HIV) and with age.
Sites (1)
- Hennepin Healthcare System, Minneapolis, Minnesota, United States